Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Douglas E. Gladstone, Franco R. D’Alessio, Christopher Howard, et al.
Blood Advances (2023) Vol. 7, Iss. 13, pp. 3075-3079
Open Access | Times Cited: 23

Showing 23 citing articles:

Differential roles of regulatory T cells in acute respiratory infections
Milica Jovisic, Nurbek Mambetsariev, Benjamin D. Singer, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 22
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 10
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 9
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes
Tapan M. Kadia, Meixian Huang, Naveen Pemmaraju, et al.
NEJM Evidence (2024) Vol. 3, Iss. 6
Closed Access | Times Cited: 6
SARS-CoV-2 Treatment: Current Perceptions and Perspectives
Denis Andreevich Shoichet, I. P. Polovikov, A. S. Sergeeva, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Progranulin promotes regulatory T cells plasticity by mitochondrial metabolism through AMPK/PGC-1α pathway in ARDS
Yanqing Chen, Minkang Guo, Ke Xie, et al.
Clinical Immunology (2024) Vol. 261, pp. 109940-109940
Closed Access | Times Cited: 4
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus
Peter F. Thall, Elizabeth Garrett‐Mayer, Nolan A. Wages, et al.
Clinical Trials (2024) Vol. 21, Iss. 3, pp. 267-272
Open Access | Times Cited: 4
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
Mi-Ae Lyu, Ximing Tang, Joseph D. Khoury, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Harnessing the biology of regulatory T cells to treat disease
Christine M. Wardell, Dominic A. Boardman, Megan K. Levings
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 3
Off-the-Shelf Allogeneic Natural Killer (NK) Cells for the Treatment of COVID-19
Winnie Liu, Eleftheria Kampouri, John Bui, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101361-101361
Open Access | Times Cited: 2
Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
Panayiota Christofi, Chrysoula Pantazi, Nikoletta Psatha, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5877-5877
Open Access | Times Cited: 5
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells
Ke Zeng, Meixian Huang, Mi-Ae Lyu, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1880-1880
Open Access | Times Cited: 4
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term Outcomes
Peter F. Thall, Yong Zang, Andrew G. Chapple, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4549-4554
Open Access | Times Cited: 4
A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease
D.T. Mengistu, Jeffrey L. Curtis, Christine M. Freeman
Trends in Immunology (2024) Vol. 45, Iss. 6, pp. 428-441
Closed Access | Times Cited: 1
Stem Cells, Cell Therapies and Bioengineering in Lung Biology and Diseases 2023
Robert E. Hynds, Chelsea M. Magin, Laertis Ikonomou, et al.
AJP Lung Cellular and Molecular Physiology (2024) Vol. 327, Iss. 3, pp. L327-L340
Open Access | Times Cited: 1
CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation
Meixian Huang, Ke Zeng, Mi-Ae Lyu, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110830-110830
Open Access | Times Cited: 1
The HIP mouse and all of its organs are completely invisible to allogeneic immune cells
Xiaomeng Hu, Kathy White, Ari G. Olroyd, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111492-111492
Open Access | Times Cited: 1
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
Ke Zeng, Hongbing Ma, Meixian Huang, et al.
Frontiers in Transplantation (2024) Vol. 3
Open Access | Times Cited: 1
Matching or genetic engineering of HLA Class I and II facilitates successful allogeneic ‘off-the-shelf’ regulatory T cell therapy
Oliver McCallion, Weijie Du, Viktor Glaser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Regulatory T lymphocytes as a treatment method for rheumatoid arthritis – Superiority of allogeneic to autologous cells
Joanna Chmiel, Mariusz Stasiak, Maria Skrzypkowska, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36512-e36512
Open Access
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0302344-e0302344
Open Access
AMP-activated protein kinase is necessary for Treg cell functional adaptation to microenvironmental stress
Manuel A. Torres Acosta, Nurbek Mambetsariev, Carla P. Reyes Flores, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top